Hi-Tech Pharmacal acquires candidiasis treatment
AMITYVILLE, N.Y. — Generic drug maker Hi-Tech Pharmacal has acquired the rights to a drug for mouth infections, the company said Monday.
Hi-Tech said it acquired nystatin oral suspension from Bausch & Lomb for an undisclosed sum. The drug is used to treat candidiasis, a fungal infection, in the mouth.
The market for the drug is $23 million, according to IMS Health.
Exergen granted new patent for TemporalScanner brand of thermometers
WATERTOWN, Mass. — Exergen said a new patent granted to the company protects its temporal artery thermometers brand.
Exergen said its portfolio of intellectual property rights has expanded with the new patent for its TemporalScanner brand of noninvasive thermometry products. Recently, Exergen said it filed a patent infringement suit in the U.S. District Court for the District of Massachusetts against Kidz-Med, American Scientific Resources and Tecnimed SRL.
"This new patent confirms and protects important innovations in noninvasive thermometry contained in our temporal artery thermometers," said Francesco Pompei, Exergen CEO and inventor of the patented technology. "These innovations are central to the overwhelming success of the temporal artery method, which many competitors would like to use. As a U.S. manufacturer, we rely on strong patent protection to protect our rights, and do our part to help protect the spirit of innovation in a highly competitive world."
Fruity Sensa offering hits market
MANHATTAN BEACH, Calif. — Shortly after announcing the launch of its weight-loss system for men, Sensa is introducing a fruity lineup of energy-enhanced vitamin drinks.
Sensa Quench, available in orange crush, pink grapefruit and berry splash flavors, is a sugar-free drink mix that when added to 12 oz. of water includes a powerful blend of natural ingredients to energize, help increase the metabolism and hydrate, according to the company.
The Sensa Quench weight-loss system is available in a 30-pack for $39.95.